Lazard Capital Markets downgrades PDL BioPharma (Nasdaq: PDLI) from Buy to Hold.

The downgrade ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE